ClinicalTrials.gg
RecruitingNCT06582173PSOMAUpdated Jul 20, 2026

Mapping the Healthcare Pathway to Multidisciplinary Assessment of 12-25 Year Olds With Somatic Symptom Disorder

An observational study in Somatic Symptoms, Medically Unexplained Symptoms and Somatoform Disorders, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
36
Ages
12 Years and older
Sex
All
01

Study summary

This study aims to describe the course of successive care events that follow individuals with somatic symptom disorder until they are assessed by a specialized multidisciplinary team. Data is collected during interviews with subjects aged 12 to 25 years old accompanied by their parents. A biographical grid is used to retrospectively identify all care events that occurred from first symptoms until multidisciplinary assessment. Life events and symptoms are collected as well to explore how history of healthcare consumption is linked to other trajectories. A qualitative analysis of the recorded interviews aims to describe the subjective experience of this healthcare pathway.

Read the detailed description

Somatic symptom disorders (SSD), previously labelled Somatoform disorders, are known to challenge healthcare professionals and systems, as those common conditions reducing quality of life often lead to excessive referrals and investigations before adequate diagnosis and management. Although studies have proved multiple interventions to be effective and cost-effective in various clinical settings, little is known about the accurate healthcare utilization associated with SSD. Such analysis faces the complexity of SSD detection and labelling due to heterogeneous clinical presentations and disputed cross-disciplinary classifications. Even though healthcare is known to be a core theme of patient experience of SSD, the investigators lack data describing the trajectory of care and the expectations, perceived help and triggering events associated with healthcare services use. A better understanding of the healthcare pathway those patients follow will help implement evidence-based treatment effectively.

The aim of this study is to trace back the pathway of care that individuals follow before they eventually undergo a specialised multidisciplinary assessment.

This descriptive study relies on data retrospectively collected from patients and their parents during face-to-face interviews assisted by a biographical grid. Inclusion criteria for patients are to be aged 12 to 25 years old and to be diagnosed with SSD by a specialised multidisciplinary team. Variables measured to describe the healthcare pathway are chosen according to professional experience and literature review. They are collected alongside concomitant life events both to reduce memory bias and to explore determinants and effects of healthcare consumption as a secondary outcome. The subjective experience of this healthcare pathway described by patients and their parents is analysed qualitatively in the verbatim of the audio recorded interview.

02

Conditions studied

  • Somatic Symptoms
  • Medically Unexplained Symptoms
  • Somatoform Disorders

Keywords

  • Somatic symptoms
  • Somatoform disorder
  • Medically unexplained symptoms
  • Healthcare pathway
  • Healthcare trajectory
  • Care episodes
  • Health Care Utilization
  • Adolescent
  • Young Adult
03

In context

Medically Unexplained Symptoms

71 studies on the registry are indexed under Medically Unexplained Symptoms; 22 are open to participants now.

This study's planned enrollment of 36 is below the median of 300 across 17 observational studies indexed under Medically Unexplained Symptoms.

Browse Medically Unexplained Symptoms studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants are selected among patients assessed in the recruiting centre, whatever their course after assessment.

The recruiting centre is an adolescent clinic which is part of a public teaching hospital in Paris, France. The centre provides inpatient and outpatient care delivered by a multidisciplinary team. Patients aged 11 to 18 can be referred to this centre by a healthcare professional or can directly access to care, regardless of their living area.

For each patient included, parents are asked to participate to research interviews to help map the healthcare pathway their child followed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Criteria relating to the population studied:

  • Age between 12 and 25 years old
  • Diagnosis of somatic symptom disorder and derivatives (DSM 5) after specialized multidisciplinary evaluation by the team of the Maison des Adolescents of Cochin hospital (Maison de Solenn).

Criteria relating to the additional population participating in the research:

- Being a parent of a subject who has received the diagnosis of somatic symptom disorder and derivatives (DSM 5) after specialized multidisciplinary evaluation at the Maison des Adolescents of Cochin Hospital (Maison de Solenn).

Exclusion criteria

Exclusion Criteria:

Criteria relating to the population studied:

  • Age less than 12 years or greater than 25 years at the time of assessment,
  • Subject presenting ongoing psychiatric decompensation, that is to say a state of mental health breaking with their baseline state and requiring rapid care which does not allow a research interview to be carried out.

Criteria relating to the additional population participating in the research:

None

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
36 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adolescents

    Patients aged 12 to 25 years old and diagnosed with SSD by a specialised multidisciplinary team

    Other: Face-to-face interviews assisted by a biographical grid

  • Parents

    Parents of an adolescent included

    Other: Face-to-face interviews assisted by a biographical grid

Interventions

  • OtherFace-to-face interviews assisted by a biographical grid

    Face-to-face interviews assisted by a biographical grid. Healthcare event of the adolescent : * medical specialist appointment * general practitioner appointment * emergency services use * hospital admission * diagnostic test * medication use * non-pharmacological treatment * nursing or physical therapy * alternative care Biographical of the adolescent : * Education event * Class/level * School * Attendance * Special arrangements * Grades * Off school education * Family event * Separation/union * Birth/death * Leave/Arrival * Location/Moving * Disease/accident * Peer events * Friendships * Love interests * Bullying * Leisure \& interests events * Activity * Frequency

06

What researchers measure

Primary outcomes

  1. Occurrence of healthcare events

    Successive healthcare events of individuals with somatic symptom disorder, from first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

Secondary outcomes

  1. Raise of healthcare events occurrence

    Raise of healthcare events occurrence following the occurrence of somatic symptoms. From first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

  2. Raise of life events occurrence

    From first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

  3. Decrease of healthcare events occurrence

    Decrease of healthcare events occurrence following the occurrence of somatic symptoms. From first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

  4. Decrease of life events occurrence

    From first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

  5. Modification of somatic symptoms occurrence

    From first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

  6. Modification of life events occurrence

    Modification of life events occurrence following healthcare. From first symptoms to specialised multidisciplinary assessment

    Time frame: Day of inclusion

  7. Qualitative analysis of the transcribed interviews

    Identification of themes emerging from the qualitative analysis of the transcribed interviews

    Time frame: Up to 24 months

07

Study locations

1 of 1 sites recruiting
  • Maison de Solenn Maison des Adolescents, Cochin Hospital
    Paris, IDF 75014, France
    Recruiting
    • Maude LUDOT-GREGOIRE, MD, PhD · Contactmaude.ludot@aphp.fr · +33 1 58 41 24 26
    • Maude LUDOT-GREGOIRE, MD · Principal investigator
08

References and documents

Publications

  • Joustra ML, Janssens KA, Bultmann U, Rosmalen JG. Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines. J Psychosom Res. 2015 Aug;79(2):94-9. doi: 10.1016/j.jpsychores.2015.05.004. Epub 2015 May 16. PubMed 26026696 ↗
  • van Dessel N, den Boeft M, van der Wouden JC, Kleinstauber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014 Nov 1;2014(11):CD011142. doi: 10.1002/14651858.CD011142.pub2. PubMed 25362239 ↗
  • Wortman MSH, Lokkerbol J, van der Wouden JC, Visser B, van der Horst HE, Olde Hartman TC. Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review. PLoS One. 2018 Oct 15;13(10):e0205278. doi: 10.1371/journal.pone.0205278. eCollection 2018. PubMed 30321193 ↗
  • Gosselin A, Desgrees du Lou A, Lelievre E; PARCOURS Study Group. How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France. J Epidemiol Community Health. 2018 Jun;72(6):507-512. doi: 10.1136/jech-2017-209739. Epub 2018 Feb 2. PubMed 29437866 ↗
  • Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018 Mar;2(3):223-228. doi: 10.1016/S2352-4642(18)30022-1. Epub 2018 Jan 30. PubMed 30169257 ↗
  • Kachaner A, Harim M, Combier A, Trouvin AP, Avouac J, Ranque B, Piot MA. Management perspectives from patients with fibromyalgia experiences with the healthcare pathway: a qualitative study. Front Med (Lausanne). 2023 Dec 1;10:1231951. doi: 10.3389/fmed.2023.1231951. eCollection 2023. PubMed 38105901 ↗
  • Hinton D, Kirk S. Families' and healthcare professionals' perceptions of healthcare services for children and young people with medically unexplained symptoms: a narrative review of the literature. Health Soc Care Community. 2016 Jan;24(1):12-26. doi: 10.1111/hsc.12184. Epub 2015 Feb 16. PubMed 25684117 ↗
  • Ludot M, Merlo M, Ibrahim N, Piot MA, Lefevre H, Carles ME, Harf A, Moro MR. ["Somatic symptom disorders" in adolescence. A systematic review of the recent literature]. Encephale. 2021 Dec;47(6):596-604. doi: 10.1016/j.encep.2021.04.007. Epub 2021 Sep 16. French. PubMed 34538623 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jun 2028, 24 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2024
First posted
Sep 3, 2024
StartActual
Jun 10, 2026
Primary completionEst.
Jun 2028
CompletionEst.
Jun 2028
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06582173
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Sep 3, 2024
Start date
Jun 10, 2026
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jul 20, 2026

Study contacts

Maude LUDOT-GREGOIRE, MD, PhD
Contact
maude.ludot@aphp.fr
+33 1 58 41 24 26
Marie BENHAMMANI-GODARD
Contact
marie.godard@aphp.fr
0033158411190
Maude LUDOT-GREGOIRE, MD, PhD
principal investigator · Maison des Adolescents - Cochin Hospital - AP-HP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion